Literature DB >> 16942465

Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Yingfei Wang1, Weibo Luo, Georg Reiser.   

Abstract

Activation of both PAR-1 (proteinase-activated receptor-1) and PAR-2 resulted in release of the chemokine GRO (growth-regulated oncogene)/CINC-1 (cytokine-induced neutrophil chemoattractant-1), a functional counterpart of human interleukin-8, from rat astrocytes. Here, we investigate whether the two PAR receptor subtypes can signal separately. PAR-2-induced GRO/CINC-1 release was independent of protein kinase C, phosphoinositide 3-kinase and MEK (mitogen-activated protein kinase kinase)-1/2 activation, whereas these three kinases were involved in PAR-1-induced GRO/CINC-1 release. Despite such clear differences between PAR-1 and PAR-2 signalling pathways, JNK (c-Jun N-terminal kinase) was identified in both signalling pathways to play a pivotal role. By isoform-specific loss-of-function studies using small interfering RNA against JNK1-3, we demonstrate that different JNK isoforms mediated GRO/CINC-1 secretion, when it was induced by either PAR-1 or PAR-2 activation. JNK2 and JNK3 isoforms were both activated by PAR-1 and essential for chemokine GRO/CINC-1 secretion, whereas PAR-1-mediated JNK1 activation was mainly responsible for c-Jun phosphorylation, which was not involved in GRO/CINC-1 release. In contrast, PAR-2-induced JNK1 activation, which failed to phosphorylate c-Jun, uniquely contributed to GRO/CINC-1 release. Therefore our results show for the first time that JNK-mediated chemokine GRO/CINC-1 release occurred in a JNK isoform-dependent fashion and invoked PAR subtype-specific mechanisms. Furthermore, here we demonstrate that activation of PAR-2, as well as PAR-1, rescued astrocytes from ceramide-induced apoptosis via regulating chemokine GRO/CINC-1 release. Taken together, our results suggest that PAR-1 and PAR-2 have overlapping functions, but can activate separate pathways under certain pathological conditions to rescue neural cells from cell death. This provides new functional insights into PAR/JNK signalling and the protective actions of PARs in brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16942465      PMCID: PMC1698669          DOI: 10.1042/BJ20060732

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs).

Authors:  R K Barr; M A Bogoyevitch
Journal:  Int J Biochem Cell Biol       Date:  2001-11       Impact factor: 5.085

2.  Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.

Authors:  Hong Wang; Joachim J Ubl; Georg Reiser
Journal:  Glia       Date:  2002-01       Impact factor: 7.452

Review 3.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 4.  Protease-activated receptors: contribution to physiology and disease.

Authors:  Valeria S Ossovskaya; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

Review 5.  The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?

Authors:  Guohua Xi; Georg Reiser; Richard F Keep
Journal:  J Neurochem       Date:  2003-01       Impact factor: 5.372

6.  The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes.

Authors:  C Blázquez; M J Geelen; G Velasco; M Guzmán
Journal:  FEBS Lett       Date:  2001-02-02       Impact factor: 4.124

7.  Purification and characterization of a trypsin-like serine proteinase from rat brain slices that degrades laminin and type IV collagen and stimulates protease-activated receptor-2.

Authors:  K Sawada; M Nishibori; N Nakaya; Z Wang; K Saeki
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

8.  Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.

Authors:  Y Morishima; Y Gotoh; J Zieg; T Barrett; H Takano; R Flavell; R J Davis; Y Shirasaki; M E Greenberg
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

9.  Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways.

Authors:  Hong Wang; Joachim J Ubl; Rolf Stricker; Georg Reiser
Journal:  Am J Physiol Cell Physiol       Date:  2002-11       Impact factor: 4.249

10.  Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1.

Authors:  Yingfei Wang; Weibo Luo; Rolf Stricker; Georg Reiser
Journal:  J Neurochem       Date:  2006-06-02       Impact factor: 5.372

View more
  18 in total

1.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

2.  Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Michael G Fehlings; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2015-08-24       Impact factor: 5.996

3.  JNK3-mediated apoptotic cell death in primary dopaminergic neurons.

Authors:  Won-Seok Choi; Heather M Klintworth; Zhengui Xia
Journal:  Methods Mol Biol       Date:  2011

4.  Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium.

Authors:  Jinshui Fan; Faoud T Ishmael; Xi Fang; Allen Myers; Chris Cheadle; Shau-Ku Huang; Ulus Atasoy; Myriam Gorospe; Cristiana Stellato
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

5.  JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death.

Authors:  Won-Seok Choi; Hyung-Wook Kim; Zhengui Xia
Journal:  Toxicology       Date:  2014-12-09       Impact factor: 4.221

6.  JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis.

Authors:  S Abdelli; J Puyal; C Bielmann; V Buchillier; A Abderrahmani; P G H Clarke; J S Beckmann; C Bonny
Journal:  Diabetologia       Date:  2009-07-16       Impact factor: 10.122

7.  c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.

Authors:  Duarte M S Ferreira; Marta B Afonso; Pedro M Rodrigues; André L Simão; Diane M Pereira; Pedro M Borralho; Cecília M P Rodrigues; Rui E Castro
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

8.  Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos).

Authors:  Yingfei Wang; No S Kim; Xiaoling Li; Peter A Greer; Raymond C Koehler; Valina L Dawson; Ted M Dawson
Journal:  J Neurochem       Date:  2009-05-13       Impact factor: 5.372

Review 9.  Role of the protease-activated receptor 1 in regulating the function of glial cells within central and peripheral nervous system.

Authors:  Elena Pompili; Cinzia Fabrizi; Francesco Fornai; Lorenzo Fumagalli
Journal:  J Neural Transm (Vienna)       Date:  2019-09-06       Impact factor: 3.575

10.  Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.

Authors:  Alexander G Vandell; Nadya Larson; Gurunathan Laxmikanthan; Michael Panos; Sachiko I Blaber; Michael Blaber; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2008-09-06       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.